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Abstract
Deletion or truncation of NS1, the principal IFN antagonist of influenza viruses, leads to increased IFN induction during
influenza virus infection. We have studied activation of the IFN induction cascade by both wild-type and NS1-defective viruses
at the single-cell level using a cell line expressing GFP under the control of the IFN-b promoter and by examining MxA
expression. The IFN-b promoter was not activated in all infected cells even during NS1-defective virus infections. Loss of
NS1 expression is therefore insufficient per se to induce IFN in an infected cell, and factors besides NS1 expression status
must dictate whether the IFN response is activated. The IFN response was efficiently stimulated in these cells following
infection with other viruses; the differential IFN response we observe with influenza viruses is therefore not cell specific but
is likely due to differences in the nature of the infecting virus particles and their subsequent replication.
The IFN arm of the innate immune response restricts virus
replication and spread during in vivo virus infections prior to
activation of the adaptive immune system. Recognition of cer-
tain viral molecular structures (pathogen-associated molecular
patterns, PAMPs) as non-self by pathogen recognition recep-
tors (PRRs) enables an infected cell to detect the presence of a
virus and activate the IFN induction cascade, leading to stimu-
lation of the IFN promoter, IFN expression and secretion. IFN
then elicits an ‘antiviral state’ in infected cells or surrounding
uninfected cells through the upregulation of hundreds of dif-
ferent interferon-stimulated genes (ISGs) that possess either
direct or indirect antiviral activity, in order to efficiently limit
further replication and spread of the virus (reviewed in
Randall and Goodbourn [1]). For influenza A viruses, a pre-
dominant PAMP is believed to be the region of partially dou-
ble-stranded, 5¢-triphosphorylated RNA that forms between
the partially complementary termini of the influenza A virus
genome segments [2, 3]; stretches of dsRNA directly adjacent
to a 5¢-triphosphate can function as ligands for the PRR RIG-
I, which has been shown to be critical for IFN induction dur-
ing influenza A virus infections [4]. However, these genome
segments do not generally exist as free RNA but are encapsi-
dated by viral nucleoprotein (NP) and polymerase to form
ribonucleoproteins (RNPs), which are likely to impact the
ability of RIG-I to recognize viral genomes. The precise origin
of influenza virus PAMPs during infection is therefore still
unclear, and contradictory reports exist on the importance of
incoming RNPs and the requirements for viral RNA synthesis
for the induction of IFN [5, 6]. Additionally, although RIG-I
has long been considered the PRR for influenza virus, MDA5
was recently implicated as performing a more significant role
in this process than previously thought [7]. Several distinct
PAMPs that stimulate different PRRs could therefore be gen-
erated during the course of an influenza virus infection.
Like other viruses, influenza virus encodes factors that antago-
nize the IFN response in order to be able to replicate effi-
ciently. Although other viral proteins have been reported to
modulate IFN expression [8–11], the principal of these is the
NS1 protein, which limits IFN expression at several different
stages of the IFN induction pathway and can additionally
inhibit the expression and/or function of ISG products down-
stream. As a result, viruses with NS1 deletions or truncations
induce large amounts of IFN and are attenuated in IFN-com-
petent systems [12–14]. The RNA-binding domain of NS1
has been implicated in preventing activation of the IFN-b pro-
moter during infection by sequestering dsRNA away from
PRRs, and recombinant viruses expressing RNA binding
mutants of NS1 induce higher levels of IFN than wild-type
(wt) virus [15–18]. NS1 also inhibits RIG-I and downstream
IFN induction by targeting the TRIM25 ubiquitin ligase that is
required for RIG-I activation [19–22]. Post-transcriptional
inhibition of IFN expression by NS1 additionally occurs
through the binding and inhibition of the 30 kDa subunit of
the cellular cleavage and polyadenylation specificity factor
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(CPSF30), which prevents the processing of all cellular pre-
mRNA 3¢-ends, thereby globally limiting the expression of
host genes including IFN-b and ISGs [23–26]. The relative
contribution of each of these functions towards overall limit-
ing of IFN expression differs between virus strains, since some
strains do not target CPSF30 while others are unable to pre-
vent IFN induction upstream of the IFN promoter [26, 27].
Most previous studies examining IFN induction by influ-
enza viruses have used methods that give an indication of
the average response across a cell population; consequently,
little information exists on the activation of innate immune
responses to influenza virus infection at the single-cell level.
In this study, we have extended our previous work into the
examination of IFN induction at the single-cell level by neg-
ative-sense RNA viruses [28–30] to study IFN induction by
influenza viruses in greater depth. Activation of the IFN
induction cascade in individual infected cells was examined
using the A549/pr(IFN-b).GFP cell line; these human lung
epithelial cells express GFP under the control of the IFN-b
promoter and consequently respond very effectively to IFN
inducers, including synthetic dsRNA and stocks of para-
myxoviruses that are rich in defective viruses (Fig. 1a, b)
[28, 30–32]. As we have reported previously [28, 29], GFP
expression in cells infected with A/Udorn/72 (Udorn;
H3N2) and A/Puerto Rico/8/34 (PR8; H1N1) influenza A
viruses was observed only in a very low percentage of
infected (i.e. NP-positive) cells (0.25 and 1.16%, respec-
tively) (Fig. 1a). While this result clearly indicates that the
majority of infected cells are negative for IFN-b.GFP
expression, this does not necessarily mean that the IFN
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Fig. 1. Failure to activate the IFN-b promoter by NS1-defective influenza A viruses. (a) A549/pr(IFN-b).GFP cells were uninfected or
infected with Ud wt, PR8 wt or Sendai virus (SeV) Cantell at 5 p.f.u. cell 1. At 16 h post-infection (p.i.), cells were trypsinized, fixed, per-
meabilized and immunostained with antibody against influenza virus NP and subsequently analysed for NP and GFP expression by
flow cytometry. Cells were divided into quadrants according to intensity of NP and GFP expression, and the percentage of cells in each
quadrant is indicated on each graph. (b) Cell lysates were generated from A549/pr(IFN-b).GFP monolayers infected with Ud wt, Ud-D
99R38A, PR8 wt or PR8-DNS1 at 5 p.f.u. cell 1 or uninfected cells for 16 h p.i., then subjected to SDS-PAGE and immunoblotting with
antibodies specific to phospho-IRF3, GFP, viral proteins and actin. (c) Cells were treated as in (b). IFN present in culture media was
estimated by a cytopathic effect-reduction bioassay [31]. Error bars represent the results of three independent experiments. (d, e)
A549/pr(IFN-b).GFP cells were uninfected or infected with Ud-D99/R38A or PR8-DNS1 at the multiplicities indicated on the plots. At 16
h p.i., cells were trypsinized, fixed, permeabilized and immunostained for influenza virus haemagglutinin or NP expression as indicated.
PIV5-VDC vM2 [32] or SeV Cantell infections were also carried out as positive controls for GFP expression. Cells were analysed by flow
cytometry as in (a). (f) Cells were infected as in (d) and (e). At 16 h p.i., cells were fixed, permeabilized and immunostained for influenza
virus NP. GFP, NP (red) and nuclei (stained with DAPI; grey) were visualized by confocal microscopy. Arrows denote those cells that
are strongly positive for virus antigen but in which GFP cannot be detected.
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induction cascade has not been activated upstream of GFP
protein expression in these GFP-negative cells. In cells
infected with certain strains of influenza virus, the IFN-b
promoter can be activated and IFN-b pre-mRNA generated,
yet mature IFN-b mRNA is not formed and IFN-b protein
is not expressed due to NS1-mediated inhibition of CPSF30
activity [27]. As such, viruses that target CPSF30 (including
Udorn wt) prevent expression from both constitutively
active and inducible promoters, which has implications for
the expression of IFN and ISGs [26]. Consistent with this,
considerable IRF3 activation (an indicator of IFN induction
upstream of the IFN-b promoter) can be detected by West-
ern blot in Udorn wt-infected A549/pr(IFN-b).GFP cells,
yet GFP expression cannot be detected (Fig. 1b). However,
this was not the case for PR8 wt-infected cells in which
IRF3 activation correlated with GFP expression (Fig. 1b),
consistent with the inability of this virus to inhibit CPSF30
[26, 33–35].
Given the well-described role of NS1 in limiting IFN induc-
tion, we sought to examine the effect of deleting NS1 on
expression of our IFN-b reporter by infecting A549/pr(IFN-
b).GFP cells with influenza viruses that lack a functional
NS1 protein. Ud-D99/R38A, a recombinant Udorn virus,
has an R38A mutation in the RNA-binding domain that
abrogates the dsRNA-binding activity of the NS1 N termi-
nus [36, 37] and lacks most of the C-terminal effector
domain of NS1 [38]. Consequently, Ud-D99/R38A also
lacks binding sites for TRIM25 and CPSF30 [19, 23, 34],
Fig. 1. (cont.)
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and IRF3 activation in cells infected with Ud-D99/R38A
therefore correlates well with GFP expression, in contrast to
cells infected with the parental Udorn wt virus (Fig. 1b).
PR8-DNS1 has a complete NS1 gene deletion in the PR8
background [12]. Consistent with a loss of IFN-antagonist
activity, both Ud-D99/R38A and PR8-DNS1 induce consid-
erably more IFN secretion from infected cell monolayers
than their respective wt viruses (Fig. 1c). When activation of
the IFN induction cascade by these viruses was examined by
flow cytometry, infection with Ud-D99/R38A and PR8-D
NS1 resulted in a higher number of GFP-positive infected
cells (Fig. 1d, e) than seen for Ud wt or PR8 wt (Fig. 1a),
due to alleviation of the NS1-mediated inhibition of IFN
expression that exists during wt virus infections. However,
strikingly, a considerable number of infected cells that were
strongly positive for viral protein remained negative for
GFP, indicating that the IFN induction cascade had not
been activated despite viral replication occurring in these
cells. In contrast, our positive controls in these experiments,
paramyxovirus preparations rich in defective viruses
(including the Cantell preparation of Sendai virus, which
like influenza virus is known to generate RIG-I ligands [2,
39]), induced GFP in the majority of infected cells (Fig. 1a,
d, f). In support of the flow cytometry data (Fig. 1d,f), Ud-D
99/R38A and PR8-DNS1-infected cells that are positive for
viral protein but negative for GFP expression were also
clearly seen by microscopy (Fig. 1f). This pattern of IFN-b
promoter activation was not due to examination of GFP
expression too early or too late in infection since it was
observed over a time course of Ud-D99/R38A infection: by
8 h p.i., the majority of cells were positive for viral NP and
GFP-positive cells could be detected in small numbers
(Fig. 2). The number of GFP-positive cells peaked at 16 h
p.i. and remained stable until 24 h, when cell death led to a
slight drop in GFP expression due to the apoptogenic nature
of the D99 NS1 deletion [38].
0
20
40
60
80
100
0
104
103
102
101
100
100 101 102 103 104
0.3
0.028
99.7 12.1
0 1.42
104
103
102
101
100
100 101 102 103 104
0.19 2.3
86.3 34.7
104
103
102
101
100
100 101 102 103 104
0.32
62.7
2.3
28.7
104
103
102
101
100
100 101 102 103 104
0.023
70.8
2 4 6 8 10 12 14 16 18 20 22 24
%
 o
f 
c
el
ls
Time (h)
NP +ve
NP +ve/
GFP +ve
N
P
 in
te
ns
ity
GFP intensity
Fig. 2. Timecourse of GFP expression in A549/pr(IFN-b).GFP cells during infection with an NS1-defective influenza A virus. A549/pr
(IFN-b).GFP cells were infected with Ud-D99/R38A at 5 p.f.u. cell 1. At the indicated times post-infection, cells were trypsinized, fixed,
permeabilized and immunostained for NP expression. GFP and NP expression were subsequently analysed by flow cytometry. The per-
centage of cells positive for NP and the percentage of cells positive for both NP and GFP at each timepoint are plotted. Flow cytometry
plots at selected timepoints are shown below the graph.
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We have clearly demonstrated that an IFN-b reporter gene
is not expressed in a subpopulation of cells infected with
NS1-defective influenza viruses, despite the multitude of
ways in which NS1 functions to limit IFN induction during
wt virus infections. We next examined expression of an
endogenous marker of activation of the IFN response, the
ISG product MxA, in A549/pr(IFN-b).GFP monolayers
infected with PR8-DNS1. Basal MxA expression was low in
uninfected cells but was upregulated following treatment
with exogenous IFN or infection with SeV Cantell (Fig. 3).
At low dilutions of PR8-DNS1, in regions of the cell mono-
layer in which several GFP-positive cells were present, the
surrounding uninfected cells were MxA positive; this was
consistent with IFN having been secreted from GFP-positive
cells and eliciting an antiviral state in neighbouring unin-
fected cells. At higher dilutions of PR8-DNS1, fields of view
containing one or two infected cells could be detected since
PR8 does not undergo multi-cycle replication in tissue cul-
ture unless trypsin is added to the culture media. In fields of
view containing NP-positive, GFP-positive cells at a high
dilution of virus, surrounding uninfected cells were positive
for MxA indicating the establishment of an antiviral state in
these cells (Fig. 3: NP-positive/GFP-positive panel). In con-
trast, uninfected cells surrounding cells that were strongly
NP positive but GFP negative were negative for MxA
(Fig. 3: NP-positive/GFP-negative panel), strongly suggest-
ing that IFN had not been secreted from these infected cells.
Using an IFN-b reporter gene system and endogenous MxA
expression studies, we have demonstrated that both wt
viruses and viruses lacking a functional NS1 protein, which
are incapable of efficiently inhibiting IFN production and
are robust activators of the IFN response in cell populations,
stimulated IFN induction pathways in only a subset of
infected cells. Thus, only a subset of infected cells is likely to
be responsible for secreting the IFN that is detectable during
both wt- and NS1-defective virus infections. A previous
study used an IFN-b-luciferase mouse model to study the
cell types responsible for IFN secretion in the infected
mouse lung, and found that luciferase expression was
restricted to relatively few epithelial cells and macrophages
that had been infected with both the wt and an NS1-deletion
mutant of the mouse-adapted H7N7 SC35M strain [40].
Furthermore, such differential expression has similarly been
noted for ISGs, with only about 20% of cells infected with
an NS1-deletion mutant of the A/Panama/2007/1999 strain
going on to express ISG15 [41]. In an in vivo study by Kal-
fass and colleagues, differences in the susceptibility of cell
types to influenza virus infection or cell-to-cell variability in
the ability to mount an IFN response may have contributed
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Fig. 3. Heterogeneity in the induction of an antiviral state in uninfected cells surrounding NS1-defective influenza A virus-infected
cells. A549/pr(IFN-b).GFP cells were infected with low or high dilutions of PR8-DNS1 as indicated, uninfected or infected with SeV Can-
tell as a positive control for GFP expression. As a positive control for MxA expression, cells were treated with IFN-a (1000 IU ml 1).
Cells were fixed at 16 h p.i., permeabilized and immunostained for influenza virus NP and MxA. Nuclear material was stained with
DAPI. GFP, MxA, NP and DAPI staining were examined by confocal microscopy. Arrows denote the positions of NP-positive cells that
are either GFP positive and surrounded by MxA-positive cells or are GFP negative and surrounded by MxA-negative cells.
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to the differential IFN-b promoter activation between cells.
In the present study, these potential sources of variability
have been eliminated; the subcloned A549/pr(IFN-b).GFP
reporter cell line can respond relatively uniformly to IFN
inducers (Fig. 1a, d–f) [28, 30, 31]. Our data thus provide
evidence that these cells are differentially mounting an IFN
response due to differences in the nature of the infecting
virus particles and their subsequent replication rather than
cell-specific factors. Indeed, we have shown previously that
different preparations of the same PR8 virus activate the
IFN response to very different degrees [29].
We have demonstrated that influenza viruses that are defec-
tive in NS1, the principal IFN antagonist, have the ability to
enter cells and replicate without leading to IFN induction.
Other viral proteins, such as PB2 or PB1-F2, have been pre-
viously reported to inhibit IFN induction [8–11], and we
cannot rule out that these proteins are actively inhibiting
IFN induction downstream of PAMP recognition in cells
infected with an NS1-deficient virus. However, we favour
the interpretation that the replication cycle of influenza
viruses is such that it is likely the virus can replicate without
generating or exposing PAMPs (e.g. by replicating in the
nucleus, in a different subcellular compartment to the cyto-
plasmic PRRs and by efficiently encapsidating the viral
RNA genome and its full-length cRNA into RNPs), thereby
preventing activation of the IFN response during normal
virus replication (reviewed in Killip et al. [29]). Further-
more, our data do not support a significant role for incom-
ing genomes in IFN induction, as has been reported
previously [6, 42], since the majority of cells infected with
NS1-defective viruses do not express markers of IFN
response activation despite all cells having been exposed to
incoming nucleocapsids. Interestingly, RIG-I has been
reported to recognize RNPs from avian influenza viruses
more readily than those from human viruses [6]; thus, spe-
cies-specific differences could exist in the number of cells
expressing IFN following infection with NS1-deficient
viruses of human or avian origin.
Our results suggest that factors in addition to NS1 expression
status determine the IFN activation status of a cell infected
with influenza virus, and that the triggering of IFN induction
pathways is likely to be associated with some form of aberrant
replication, e.g. inefficient genome encapsidation, the genera-
tion of aberrant RNA products or the replication of defective
genomes. There is accumulating evidence pointing to the
involvement of the latter in this process [2, 29, 43–48], and a
link between defective genomes and IFN induction is
well documented for other negative-sense RNA virus families.
Thus, rather than being required to limit IFN production in
cells in which virus is replicating normally, the primary func-
tion of NS1 may be to limit IFN induction in the event of these
aberrant replication events occurring.
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